INNO-LiPA HLA-C Amplification - Taiwan Registration 1adf9dcafebe615d9fd0408fa26715db

Access comprehensive regulatory information for INNO-LiPA HLA-C Amplification in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 1adf9dcafebe615d9fd0408fa26715db and manufactured by FUJIREBIO EUROPE N.V.. The authorized representative in Taiwan is Taiwan Fu Pharmaceutical Co., Ltd.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.